| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |